First human test of new drug completed

NCT ID NCT06103877

Summary

This was the first study in people to test the safety of an experimental drug called AZD1163. It involved 108 healthy volunteers who received either the drug or a placebo via injection. The main goal was to see how well the drug was tolerated, how it moved through the body, and if it triggered an immune response.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Glendale, California, 91206, United States

  • Research Site

    Brooklyn, Maryland, 21225, United States

  • Research Site

    Berlin, 14050, Germany

Conditions

Explore the condition pages connected to this study.